Procedure: tuberculin skin test (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00491933 (ClinicalTrials.gov) | June 2007 | 25/6/2007 | Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFa Antagonists | Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in the Assessment of Latent Mycobacterium Tuberculosis Infection in Patients Candidate to Treatment or Treated With TNFa Antagonists | Rheumatoid Arthritis;Spondylarthritis;Tuberculosis | Procedure: Quantiferon-TB Gold assay;Procedure: Tuberculin skin test | Ospedale L. Sacco – Polo Universitario | NULL | Recruiting | 18 Years | 80 Years | Both | 100 | N/A | Italy |